{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "April 23, 2024: Patient experienced weakness and numbness in the upper limbs, progressively worsening symptoms, an inability to stand or walk, and difficulty in making a fist with both hands. Physical examination revealed bilateral upper limb muscle strength is three out of five and lower limb muscle strength is two out of five. Sensory examinations were normal, including pain, temperature, vibration, and position sense.",
        "clinical_data": {
          "HPI": [
            {
              "summary": "Patient experienced weakness and numbness in the upper limbs, progressively worsening symptoms, an inability to stand or walk, and difficulty in making a fist with both hands.",
              "onset": "2024-04-23",
              "progression": "gradual",
              "associated_symptoms": [
                "C0043070",
                "C0234850"
              ]
            }
          ],
          "vitals": [
            {
              "type": "Muscle strength",
              "value": "3/5",
              "unit": "MRC scale",
              "timestamp": "2024-04-23"
            },
            {
              "type": "Muscle strength",
              "value": "2/5",
              "unit": "MRC scale",
              "timestamp": "2024-04-23"
            }
          ],
          "diagnoses": [
            {
              "code": "C0043070",
              "label": "Weakness",
              "status": "active",
              "onset_date": "2024-04-23"
            },
            {
              "code": "C0234850",
              "label": "Numbness",
              "status": "active",
              "onset_date": "2024-04-23"
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "Patient neurological evaluation: No Babinski sign or exaggerated deep tendon reflexes. Cranial and cervical MRI: Negative for space-occupying lesions. Nerve conduction study: Lower amplitude in the right median nerve, bilateral tibia, and bilateral common peroneal nerve CMAP and reduced conduction velocity in the right common peroneal nerve; SNAPs were normal. F wave: Decrease in the outgoing wave rate of the bilateral median nerve and bilateral tibial nerves.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Nerve conduction studies",
              "date": null,
              "location": null,
              "performed_by": null,
              "outcome": null
            }
          ],
          "imaging": [
            {
              "type": "MRI of cranial and cervical spine",
              "body_part": "Cranial and cervical spine",
              "modality": "MRI",
              "finding": "Negative for space-occupying lesions",
              "impression": "Negative for space-occupying lesions",
              "date": null
            }
          ],
          "neuro_exam": [
            {
              "finding": "No Babinski sign",
              "timestamp": null
            },
            {
              "finding": "No exaggerated deep tendon reflexes",
              "timestamp": null
            }
          ],
          "labs": [
            {
              "test": "CMAP of right median nerve",
              "value": "Lower amplitude",
              "unit": null,
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "CMAP of bilateral tibia",
              "value": "Lower amplitude",
              "unit": null,
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "CMAP of bilateral common peroneal nerve",
              "value": "Lower amplitude",
              "unit": null,
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "Conduction velocity of right common peroneal nerve",
              "value": "Reduced",
              "unit": null,
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "SNAPs",
              "value": "Normal",
              "unit": null,
              "flag": "normal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "F wave of bilateral median nerve",
              "value": "Decrease in the outgoing wave rate",
              "unit": null,
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "F wave of bilateral tibial nerves",
              "value": "Decrease in the outgoing wave rate",
              "unit": null,
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Lumbar puncture: Normal pressure, elevated CSF protein (0.97 g/L; normal 0.01-0.45 g/L), normal nucleated cell count (1.0 * 10^6/L; normal 0-8.0*10^6/L). CSF cytology, culture, and smear: Negative. CSF shed cells: No tumor cells found. Serum autoimmune and ANCA antibodies: Negative.",
        "clinical_data": {
          "labs": [
            {
              "test": "Lumbar puncture",
              "value": "normal pressure",
              "unit": null,
              "flag": "normal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "Cerebrospinal Fluid Protein Measurement",
              "value": "0.97",
              "unit": "g/L",
              "flag": "abnormal",
              "reference_range": "0.01-0.45 g/L",
              "timestamp": null
            },
            {
              "test": "Nucleated Cell Count",
              "value": "1.0",
              "unit": "* 10^6/L",
              "flag": "normal",
              "reference_range": "0-8.0*10^6/L",
              "timestamp": null
            },
            {
              "test": "CSF cytology",
              "value": "Negative",
              "unit": null,
              "flag": "normal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "Culture",
              "value": "Negative",
              "unit": null,
              "flag": "normal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "Smear",
              "value": "Negative",
              "unit": null,
              "flag": "normal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "CSF shed cells",
              "value": "No tumor cells found",
              "unit": null,
              "flag": "normal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "Serum autoimmune antibodies",
              "value": "Negative",
              "unit": null,
              "flag": "normal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "ANCA antibodies",
              "value": "Negative",
              "unit": null,
              "flag": "normal",
              "reference_range": null,
              "timestamp": null
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "CSF analysis: IgG oligoclonal bands in CSF were similar to serum (type IV CSF and serum). IgG 24-h intrathecal synthesis rate: 10.04 mg/24 h (reference range < 7mg/24 h). Ganglioside antibody detection: IgM positive for anti-GM1, anti-GM2, and anti-GD2 antibodies. Paraneoplastic syndrome antibodies in CSF and serum: anti-Hu antibodies positive; anti-Ri, anti-CV2, anti-amphiphysin, anti-Ma1, anti-Ma2, anti-SOX1, anti-DNER, anti-Zic4, anti-titin, anti-recovery, anti-PKC, anti-GAD65, and anti-Yo antibodies negative.",
        "clinical_data": {
          "labs": [
            {
              "test": "Oligoclonal Band Presence in Cerebrospinal Fluid",
              "value": "positive",
              "unit": null,
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "IgG 24-h intrathecal synthesis rate",
              "value": "10.04",
              "unit": "mg/24 h",
              "flag": "abnormal",
              "reference_range": "< 7mg/24 h",
              "timestamp": null
            },
            {
              "test": "Anti-GM1 IgM antibody",
              "value": "positive",
              "unit": null,
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "Anti-GM2 IgM antibody",
              "value": "positive",
              "unit": null,
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "Anti-GD2 IgM antibody",
              "value": "positive",
              "unit": null,
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "Anti-Hu antibody",
              "value": "positive",
              "unit": null,
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "Anti-Ri antibody",
              "value": "negative",
              "unit": null,
              "flag": "normal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "Anti-CV2 antibody",
              "value": "negative",
              "unit": null,
              "flag": "normal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "Anti-amphiphysin antibody",
              "value": "negative",
              "unit": null,
              "flag": "normal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "Anti-Ma1 antibody",
              "value": "negative",
              "unit": null,
              "flag": "normal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "Anti-Ma2 antibody",
              "value": "negative",
              "unit": null,
              "flag": "normal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "Anti-SOX1 antibody",
              "value": "negative",
              "unit": null,
              "flag": "normal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "Anti-DNER antibody",
              "value": "negative",
              "unit": null,
              "flag": "normal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "Anti-Zic4 antibody",
              "value": "negative",
              "unit": null,
              "flag": "normal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "Anti-titin antibody",
              "value": "negative",
              "unit": null,
              "flag": "normal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "Anti-recovery antibody",
              "value": "negative",
              "unit": null,
              "flag": "normal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "Anti-PKC antibody",
              "value": "negative",
              "unit": null,
              "flag": "normal",
              "reference_range": null
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "Diagnosis: anti-Hu positivity associated with adebrelimab-induced paraneoplastic neuropathy. Treatment: Adebrelimab was discontinued. Methylprednisolone sodium succinate at 1000 mg/day plus immunoglobulin (0.4 g/kg/d) 20 g/day was administered for 5 days. Post-treatment: Bilateral upper limb muscle strength improved to four out of five, lower limb muscle strength improved to three out of five, and symptoms improved; however, the patient was still unable to stand and walk.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C1522440",
              "label": "Paraneoplastic Neurologic Syndrome",
              "status": "active",
              "onset_date": null
            }
          ],
          "medications": [
            {
              "drug": "adebrelimab",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": "paraneoplastic neuropathy"
            },
            {
              "drug": "Methylprednisolone Sodium Succinate",
              "dosage": "1000 mg/day",
              "frequency": "daily",
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "immunoglobulin",
              "dosage": "0.4 g/kg/d",
              "frequency": "daily",
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ],
          "functional_status": [
            {
              "domain": "mobility",
              "description": "Bilateral upper limb muscle strength improved to four out of five, lower limb muscle strength improved to three out of five, and symptoms improved; however, the patient was still unable to stand and walk.",
              "score": null,
              "scale": null
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "Patient developed progressive bilateral symmetrical limb weakness, separation of the CSF protein cells, and peripheral nerve axonal degeneration with demyelinating changes, primarily axonal damage. Anti-GM1, anti-GM2, and anti-GD2 IgM antibodies were positive, anti-Hu antibodies were positive after two cycles of ICI treatment, and the final diagnosis was PNS. Autoimmune encephalitis antibodies (anti-NMDA, anti-LGI1, anti-CASPR2, anti-AMPAR1, and anti-AMPAR2) were not detected because of insufficient CSF samples.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0030930",
              "label": "Peripheral neuropathy",
              "status": "active"
            }
          ],
          "labs": [
            {
              "test": "C0151675",
              "value": "positive",
              "unit": null,
              "flag": null,
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "C0151675",
              "value": "positive",
              "unit": null,
              "flag": null,
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "C0151675",
              "value": "positive",
              "unit": null,
              "flag": null,
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "C0151675",
              "value": "positive",
              "unit": null,
              "flag": null,
              "reference_range": null,
              "timestamp": null
            }
          ],
          "HPI": [
            {
              "summary": "progressive bilateral symmetrical limb weakness",
              "duration": null,
              "onset": null,
              "progression": "gradual",
              "associated_symptoms": [
                "C0270538"
              ],
              "alleviating_factors": [],
              "exacerbating_factors": []
            }
          ]
        }
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Neurological evaluation and imaging were performed to investigate the patient's weakness and numbness.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "C0030927"
          ],
          "change_type": "other",
          "target_domain": "diagnosis"
        }
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Further investigation with lumbar puncture to evaluate CSF.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "C0024242"
          ],
          "change_type": "other",
          "target_domain": "diagnosis"
        }
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Detailed CSF analysis including IgG and ganglioside antibody detection.",
        "transition_event": {
          "trigger_type": "lab_change",
          "trigger_entities": [
            "C0009766"
          ],
          "change_type": "other",
          "target_domain": "lab"
        }
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Diagnosis of anti-Hu positivity associated with adebrelimab-induced paraneoplastic neuropathy and initiation of treatment with discontinuation of adebrelimab, methylprednisolone, and immunoglobulin.",
        "transition_event": {
          "trigger_type": "interpretation",
          "trigger_entities": [
            "C1522440",
            "C4720824"
          ],
          "change_type": "addition",
          "target_domain": "diagnosis"
        }
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Patient developed progressive bilateral symmetrical limb weakness, separation of the CSF protein cells, and peripheral nerve axonal degeneration with demyelinating changes, primarily axonal damage. Anti-GM1, anti-GM2, and anti-GD2 IgM antibodies were positive, anti-Hu antibodies were positive after two cycles of ICI treatment, and the final diagnosis was PNS.",
        "transition_event": {
          "trigger_type": "progression",
          "trigger_entities": [
            "C0043070"
          ],
          "change_type": "progression",
          "target_domain": "symptom"
        }
      }
    }
  ]
}